Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants
- 1 March 1999
- Vol. 17 (9-10) , 1074-1083
- https://doi.org/10.1016/s0264-410x(98)00324-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral immunization with recombinant vaccinia expressing cell-surface-anchored βhCG induces anti-hCG antibodies and T-cell proliferative response in ratsVaccine, 1997
- Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proceedings of the National Academy of Sciences, 1996
- Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virusVaccine, 1994
- Enteric immunization of mice against influenza with recombinant vaccinia.Proceedings of the National Academy of Sciences, 1994
- Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.Proceedings of the National Academy of Sciences, 1989
- Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.Proceedings of the National Academy of Sciences, 1988
- Development of a Vaccinia-Rabies Glycoprotein Recombinant Virus VaccinePublished by Springer Nature ,1988
- Isolation and characterization of attenuated mutants of vaccinia virusVirology, 1987
- Live recombinant vaccinia virus protects chimpanzees against hepatitis BNature, 1984
- Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.Proceedings of the National Academy of Sciences, 1983